eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
KSCP Knightscope
- 4.990
- +0.250+5.27%
Close Apr 30 16:00 ET
- 5.050
- +0.060+1.20%
Post 18:42 ET
34.44MMarket Cap-0.45P/E (TTM)
4.990High4.521Low109.90KVolume4.700Open4.740Pre Close525.72KTurnover1.69%Turnover RatioLossP/E (Static)6.90MShares28.57152wk High2.18P/B32.45MFloat Cap2.45052wk Low--Dividend TTM6.50MShs Float1375.000Historical High--Div YieldTTM9.90%Amplitude2.450Historical Low4.783Avg Price1Lot Size
Knightscope Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.57%10.81M | -6.64%2.81M | -23.74%2.54M | -10.10%3.2M | -22.20%2.25M | 127.26%12.8M | 28.21%3.01M | 156.48%3.32M | 241.94%3.56M | 206.89%2.9M |
| Operating revenue | -15.57%10.81M | -6.64%2.81M | -23.74%2.54M | -10.10%3.2M | -22.20%2.25M | 127.26%12.8M | 28.21%3.01M | 156.48%3.32M | 241.94%3.56M | 206.89%2.9M |
| Cost of revenue | -2.14%14.5M | -21.99%3.81M | -1.19%3.24M | 5.82%3.76M | 18.94%3.7M | 65.60%14.82M | 38.33%4.88M | 49.16%3.27M | 105.20%3.55M | 108.31%3.11M |
| Gross profit | -82.76%-3.7M | 46.74%-996K | -1,500.00%-700K | -6,300.00%-558K | -578.40%-1.45M | 39.02%-2.02M | -58.47%-1.87M | 105.56%50K | 101.30%9K | 61.20%-213K |
| Operating expense | 5.61%25.47M | 6.73%5.84M | 7.27%7.01M | -0.69%5.91M | 8.96%6.72M | -15.83%24.12M | -27.81%5.47M | -4.99%6.53M | -9.09%5.95M | -19.47%6.16M |
| Selling and administrative expenses | 3.63%18.41M | -3.79%3.75M | 13.13%5.24M | -4.39%4.27M | 7.97%5.15M | -12.06%17.76M | -23.68%3.9M | -3.66%4.63M | -0.04%4.47M | -18.04%4.77M |
| -Selling and marketing expense | -0.71%5.14M | -24.88%1.1M | -28.32%1M | 28.83%1.54M | 33.51%1.51M | -39.07%5.18M | -8.28%1.46M | -26.85%1.4M | -20.94%1.19M | -67.68%1.13M |
| -General and administrative expense | 5.41%13.27M | 8.86%2.65M | 31.00%4.24M | -16.49%2.73M | 0.05%3.64M | 7.56%12.59M | -30.67%2.44M | 11.59%3.24M | 10.61%3.27M | 56.45%3.64M |
| Research and development costs | 11.18%7.06M | 32.89%2.09M | -6.99%1.77M | 10.46%1.64M | 12.31%1.57M | -24.83%6.35M | -36.37%1.57M | -8.07%1.9M | -28.58%1.48M | -23.99%1.4M |
| Operating profit | -11.59%-29.17M | 6.89%-6.83M | -18.90%-7.71M | -8.86%-6.47M | -27.98%-8.16M | 18.23%-26.14M | 16.18%-7.34M | 16.62%-6.48M | 17.89%-5.94M | 22.26%-6.38M |
| Net non-operating interest income expense | 23.23%-423K | -12.36%-100K | -1,525.00%-130K | -366.67%-128K | 87.05%-65K | 94.03%-551K | 72.62%-89K | -8K | 4,700.00%48K | 94.37%-502K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | -87.05%65K | ---- | ---- | ---- | ---- | -94.37%502K |
| Total other finance cost | -23.23%423K | 12.36%100K | 1,525.00%130K | 366.67%128K | ---- | --551K | --89K | --8K | -4,700.00%-48K | ---- |
| Other net income (expense) | -146.87%-2.14M | -103.80%-34K | -65.64%-3.07M | -70.48%323K | -85.70%634K | -70.62%4.57M | 134.45%894K | -172.96%-1.85M | -86.50%1.09M | -41.00%4.44M |
| Gain on sale of security | -130.86%-1.52M | --0 | -64.78%-2.97M | -42.92%681K | -83.34%770K | -76.46%4.91M | -66.44%895K | -170.78%-1.8M | -85.32%1.19M | -38.55%4.62M |
| Special income (charges) | -242.28%-510K | ---63K | ---33K | -5,800.00%-295K | 17.36%-119K | ---149K | --0 | --0 | ---5K | ---144K |
| -Less：Restructuring and merger&acquisition | 242.28%510K | --63K | --33K | 5,800.00%295K | -17.36%119K | --149K | --0 | --0 | --5K | --144K |
| Other non- operating income (expenses) | 37.57%-118K | 3,000.00%29K | -31.37%-67K | 32.98%-63K | 60.47%-17K | 96.43%-189K | 99.98%-1K | -750.00%-51K | -291.67%-94K | -760.00%-43K |
| Income before tax | -43.48%-31.73M | -6.63%-6.97M | -30.71%-10.9M | -30.70%-6.27M | -210.64%-7.59M | 13.75%-22.12M | 44.04%-6.53M | -59.26%-8.34M | -652.76%-4.8M | 74.53%-2.44M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -43.48%-31.73M | -6.63%-6.97M | -30.71%-10.9M | -30.70%-6.27M | -210.64%-7.59M | 13.75%-22.12M | 44.04%-6.53M | -59.26%-8.34M | -652.76%-4.8M | 74.53%-2.44M |
| Net income continuous Operations | -43.48%-31.73M | -6.63%-6.97M | -30.71%-10.9M | -30.70%-6.27M | -210.64%-7.59M | 13.75%-22.12M | 44.04%-6.53M | -59.26%-8.34M | -652.76%-4.8M | 74.53%-2.44M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -43.48%-31.73M | -6.63%-6.97M | -30.71%-10.9M | -30.70%-6.27M | -210.64%-7.59M | 13.75%-22.12M | 44.04%-6.53M | -59.26%-8.34M | -652.76%-4.8M | 74.53%-2.44M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -43.48%-31.73M | -6.63%-6.97M | -30.71%-10.9M | -30.70%-6.27M | -210.64%-7.59M | 13.75%-22.12M | 44.04%-6.53M | -59.26%-8.34M | -652.76%-4.8M | 74.53%-2.44M |
| Basic earnings per share | 34.59%-10.97 | 78.69%-0.78 | 33.21%-3.58 | 37.50%-2.5 | -33.33%-4 | 53.42%-16.77 | 77.13%-3.66 | 23.43%-5.36 | -500.00%-4 | 80.00%-3 |
| Diluted earnings per share | 34.59%-10.97 | 78.69%-0.78 | 33.21%-3.58 | 37.50%-2.5 | -33.33%-4 | 53.42%-16.77 | 77.13%-3.66 | 23.43%-5.36 | -500.00%-4 | 80.00%-3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀